KDM6B and Hodgkins lymphoma: In particular, JMJD3 plays an oncogenic role in various tumors such as cancer of the kidneys, breast, prostate, skin, hematopoietic system, melanoma, Hodgkin’s lymphoma (HL), myelodysplastic syndrome (MDS), esophageal squamous cell carcinoma, and ovarian cancer [74].